BMY
Bristol-Myers SquibbBNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
BMY vs peer average
53/100
BMY vs. peer average (B vs. B)
Grade spread
A 2 · B 6 · C 1 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
JNJ is the first available peer comparator.
Large diversified pharma with broad consumer/medtech exposure; defensive revenue mix compared with BMY's oncology focus.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
BMY
Bristol-Myers Squibb
JNJ
Johnson Johnson
Grade
B
B
Momentum
67
72
Value
67
60
Sentiment
45
55
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs JNJ
BMY / JNJ
Grade Position
In line
BMY vs. peer average (B vs. B)
53/100
Momentum
67
JNJValue
67
BMYSentiment
45
JNJRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs BMY
JNJ is the first peer returned for this comparison set.